Structured medication review service
Structured Medication Reviews (SMRs) — targeted, structured, outcomes-driven.
What we deliver
The work, end-to-end.
Most SMRs delivered in primary care today are activity, not outcomes. BCS runs SMRs as part of a structured programme: defined cohort, defined intervention, measurable impact.
- Cohort identification using SystmOne/EMIS searches
- Pre-review preparation and risk stratification
- Patient-facing SMR consultations (face-to-face, telephone or video)
- Prescribing changes documented and actioned
- Outcomes coded against IIF and QOF indicators
- Outputs fed into the BCS Impact Dashboard
Outcomes
Measurable outcomes — every month.
Tracked in the BCS Impact Dashboard. Reported to your PCN every month. QA signed-off.
- Number of SMRs completed by cohort
- Average number of medicines stopped per review
- High-risk monitoring gaps closed
- IIF/QOF indicator improvements
- GP appointments avoided through SMR follow-up
DES 26/27 alignment
How this maps to the Network Contract DES.
Directly delivers PCN responsibilities under the Network Contract DES 26/27 Service Requirements for medication reviews and medicines optimisation, with outputs that support IIF achievement.
FAQs
Common questions from PCN Clinical Directors.
Do you use our clinical system?+
Yes — we work in your SystmOne, EMIS or Vision instance with full audit trails. No third-party systems required.
How are cohorts selected?+
We agree priority cohorts with your Clinical Director at onboarding — typically polypharmacy 65+, high-risk medicines, and LTC patients out of target. Cohorts are refreshed quarterly.
How is quality assured?+
Every SMR is documented to a BCS template; a sample of reviews is audited monthly by the QA function independent of delivery.
Talk to our Service Development team
30-minute discovery call. We'll show you how BCS maps to your PCN's specific priorities.
